Plain-English translation of NCT04834518 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This is a large screening study for young children across Israel designed to detect very early signs of type 1 diabetes before symptoms appear. Researchers will test up to 50,000 children between 9 months and 5 years old using a new, extremely sensitive blood test that can catch warning signs years earlier than standard tests. Children who show positive results will be monitored closely and offered family support and education.
Type 1 diabetes often develops silently before children show any symptoms. By catching the early warning signs through this new, highly sensitive test, doctors hope to identify at-risk children earlier and help families prepare for or potentially prevent the disease from progressing.
You likely qualify if…
You likely don't qualify if…
Your child will have a small blood sample taken at their regular doctor visit around age 1 year (done at the same time as routine blood work). If that test is negative, you'll be invited back for repeat screening at ages 2 through 5. If antibodies (warning signs) are detected, your child will have additional testing and regular follow-up visits to monitor for diabetes development, and your family will be invited to join an educational program about diabetes prevention and management.
AI-generated summary from trial data · Aug 20, 2026 · Not medical advice
Israel